ADGM M&A Transactions: Regulatory Framework and Compliance

Where minority rights, FSRA approval and the target's regulatory record shape an ADGM deal

How the ADGM Companies Regulations 2020 bear on a deal through fiduciary duties, minority remedies, capital changes and transfer restrictions. It then sets out what the FSRA weighs before approving a change of control in a regulated firm, what due diligence and the transaction documents should cover, and the restructuring, post-completion and cross-border issues that follow.

By Nour Attorneys / 22 August 2026

Reviewed by Mohamed Noureldin, Founder, Managing Partner & Senior Legal Consultant

Where an ADGM company has multiple minority shareholders, a deal could be delayed or blocked by rights in pre-existing shareholders' agreements, such as a right of first refusal held by a third party. Where the target is a regulated firm, certain transactions require prior approval from the Financial Services Regulatory Authority (FSRA).

ADGM is a financial free zone with a legal system distinct from the UAE's mainland civil law framework. It relies on common law principles, which significantly influence how M&A transactions are structured and executed. Parties must structure their transactions to conform to local ADGM regulations and to established international protocols in corporate governance and financial regulation.

Related services: Explore our AML compliance advisory and mergers and acquisitions services for practical legal support in this area.

Fiduciary duties and minority protections in an ADGM company

The ADGM Companies Regulations 2020 govern corporate entities in ADGM and provide the foundational legal framework for M&A transactions involving ADGM companies. They provide for the formation, governance and dissolution of companies. They also set rules on share transfers, capital adjustments and shareholder rights, all of which are critical levers in a deal.

The Regulations place emphasis on shareholder protection and transparency. Unlike many civil law jurisdictions, they apply common law doctrines such as fiduciary duties and equitable principles to address conflicts during M&A negotiations. Directors owe fiduciary duties that must be balanced against shareholder interests, especially in transactions involving potential conflicts of interest or an imbalance of information.

The Regulations also provide mechanisms for minority shareholder protection, including rights to challenge unfair prejudice and procedural safeguards for the approval of significant transactions. These provisions require M&A structures that accommodate potential challenges from dissenting stakeholders. Designing the transaction with them in mind can mitigate litigation risk and regulatory scrutiny.

Pre-emption, notice, voting and unfair prejudice

The Companies Regulations detail specific rights that shareholders may exercise during M&A transactions. They include pre-emption rights, the right to receive notice of meetings, and rights to vote on resolutions affecting the company's structure. Shareholders may also petition the ADGM courts under the unfair prejudice provisions on the ground that the company's affairs are being or have been conducted in a manner unfairly prejudicial to their interests.

Suppose a controlling shareholder seeks to merge the company with another entity on terms that undervalue the minority stake. The minority shareholders may seek relief through the ADGM courts. If the courts are satisfied that the petition is well founded, they may make such order as they think fit for giving relief in respect of the matters complained of.

Conditions on capital changes and share transfers

M&A transactions often require adjustments to share capital, including capital increases, reductions or reclassifications. The Companies Regulations impose procedural and substantive conditions on such adjustments to prevent abuse and protect creditor and shareholder interests.

A reduction in share capital to return capital to shareholders or to write off losses, for instance, must follow prescribed steps. A private company limited by shares may use a special resolution supported by a solvency statement; any company may use a special resolution confirmed by the Court.

The transfer of shares is itself a critical structural component of a deal. The Companies Regulations allow companies to impose restrictions on share transfers through articles of association or shareholders' agreements. Such restrictions may include rights of first refusal, tag-along rights or drag-along provisions.

These mechanisms are particularly important in unequal ownership structures where minority shareholders seek to protect their interests. Tag-along rights, for example, enable minority shareholders to exit on the same terms as the majority in the event of a sale, which guards against their exclusion.

Change of control in a regulated firm requires prior FSRA approval

The FSRA oversees M&A transactions that involve regulated entities in ADGM, particularly financial institutions, investment firms and entities licensed under the ADGM Financial Services and Markets Regulations (FSMR). Its mandate includes ensuring market stability, protecting consumers and maintaining the integrity of the ADGM financial ecosystem.

Certain types of M&A transaction require prior FSRA approval. Where the regulated firm is a Domestic Firm, a person must not become a Controller, or increase its level of control beyond a specified threshold, without the FSRA's prior written approval. The FSRA applies a rigorous review. It assesses the transaction's impact on financial soundness, compliance capacity and adherence to anti-money laundering and counter-terrorism financing (AML/CTF) regulations.

What the FSRA weighs

The FSRA evaluates several key factors when it considers an M&A transaction:

Fit and proper persons test: whether the prospective owners and controllers meet standards of honesty, integrity, competence and financial soundness.
Financial stability: acquirers must demonstrate sufficient capital resources to maintain the financial health of the regulated entity.
Governance and compliance: proposed changes must preserve or enhance governance frameworks and compliance with AML/CTF obligations.
Impact on market integrity: whether the transaction could adversely affect market confidence or systemic stability.

Each of these criteria must be met to answer the FSRA's concerns and to avoid outcomes such as suspension of the transaction or enforcement action.

The application and the review period

The approval process involves submitting a detailed application with extensive documentation, including business plans, financial projections and fit and proper declarations. Where the FSRA proposes to approve, it must do so as soon as practicable and in any event within 90 days of receiving a duly completed application, unless it considers a different period appropriate and notifies the applicant in writing.

To keep the timetable efficient, parties should engage with the FSRA early, conduct pre-application consultations and prepare full disclosures. Failure to account for these factors can result in significant delays or conditional approvals, which adversely affect transaction certainty.

A private equity firm buying control of a regulated investment firm

Take a private equity firm that seeks a controlling stake in an ADGM-regulated investment firm. The FSRA will scrutinise the private equity firm's owners and controllers under the fit and proper test, examine the acquirer's capital adequacy and assess plans for governance after the acquisition.

A failure to demonstrate adequate compliance frameworks, or to disclose adverse regulatory history, may lead to refusal or to conditions that complicate integration. Structuring the transaction to include escrow arrangements for regulatory indemnities, and preparing management continuity plans, can address the FSRA's concerns and help obtain approval.

Checking the target's regulatory record, contracts and shareholder rights

Due diligence is a critical phase in any M&A transaction. In ADGM it assumes greater complexity because of the dual regulatory regime and the presence of regulated entities. It involves financial and operational audits, and also an in-depth review of regulatory compliance history, licensing status, contractual obligations and corporate governance frameworks.

Particular attention must be paid to compliance with the ADGM Companies Regulations and FSRA mandates, including records of regulatory filings, past enforcement actions and the adequacy of anti-money laundering controls.

Compliance with FSMR obligations

Given the FSRA's active regulatory role, due diligence must incorporate verification of the target's adherence to FSMR obligations, including AML/CTF policies, sanctions screening and reporting protocols. Any past breaches or investigations represent structural risks that must be reflected in deal valuation and risk allocation.

Discovering unresolved FSRA enforcement actions, for example, may warrant specific indemnities or escrow mechanisms to cover potential future liabilities. Structuring for this in advance serves to mitigate disputes arising from regulatory non-compliance.

Change of control clauses and third-party consents

Due diligence also covers existing contractual obligations that may affect the deal. These include change of control provisions, anti-assignment clauses and third-party consents. Failure to identify such clauses can result in breaches after the transaction, leading to costly litigation or regulatory sanctions.

Mapping these contractual relationships, and settling appropriate waiver or consent strategies, is essential. It limits surprises during integration.

Rights under existing shareholders' agreements

In a deal involving multiple minority shareholders, due diligence should reveal any pre-existing shareholders' agreements that impose restrictions on transfers or grant rights that could delay or block the transaction. A right of first refusal held by a third party, for instance, may require negotiation or waiver before the deal can close. Early engagement with these stakeholders, and contractual accommodations designed for them, can reduce the risk of a hold-up.

Transaction documents that allocate regulatory risk

Contract drafting in ADGM M&A transactions must reflect the jurisdiction's unique legal environment and regulatory requirements. Transaction documents must incorporate compliance provisions aligned with the ADGM Companies Regulations and FSRA requirements. This includes drafting share purchase agreements (SPAs), shareholders' agreements and ancillary contracts with precise representations, warranties and conditions precedent linked to regulatory approvals.

Key contractual provisions

Material adverse change (MAC) clauses allow parties to terminate or renegotiate the deal if significant negative developments occur. In ADGM M&A, MAC clauses should be carefully tailored to reflect regulatory risks, such as changes in FSRA policy or adverse enforcement outcomes.
Regulatory termination rights. Given the FSRA's approval powers, contracts must accommodate termination or suspension rights if regulatory consent is denied or delayed. This requires clear articulation of the process and its consequences.
Dispute resolution mechanisms. Arbitration clauses or choice of court provisions are vital to resolve any post-closing disputes efficiently. ADGM courts offer expertise in commercial law, but parties may prefer arbitration under internationally recognised rules to avoid jurisdictional complexities.

Disclosure schedules and representations

In M&A transactions one party inherently possesses superior knowledge about the target or the acquirer. Within ADGM, the layered regulatory regime and the presence of regulated entities compound that imbalance. Parties must use legal mechanisms to mitigate these risks. One primary method is detailed disclosure schedules and representations.

Sellers must disclose all material facts, including regulatory risks, financial liabilities and pending litigation. Buyers rely on these disclosures to validate their valuation and risk assessment. Full disclosure requirements and warranties in the SPA are essential to a balanced risk allocation. Failure to disclose material information can lead to rescission claims or indemnity obligations, which create post-closing disputes.

Escrow and holdbacks

To mitigate the risk of undisclosed liabilities or breaches, parties often establish escrow accounts or holdbacks. These retain a portion of the purchase price for a defined period, so that funds are available to satisfy indemnity claims or regulatory penalties. If due diligence uncovers potential unresolved regulatory compliance issues, for example, an escrow can cover future financial exposure and incentivise truthful disclosure.

Redomiciliation, holding companies and capital reorganisation

Corporate restructuring frequently accompanies M&A transactions to optimise the structure of the combined entity. This includes:

Redomiciliation: continuing a body corporate incorporated outside ADGM as an ADGM company, or an ADGM company in another jurisdiction with the Registrar's authorisation, to take advantage of regulatory benefits or operational efficiencies.
Holding company formation: establishing a holding entity within ADGM to consolidate shareholdings and centralise governance.
Share capital reorganisation: adjusting the capital structure to reflect new ownership patterns and satisfy regulatory capital requirements.

Each restructuring step must comply with the ADGM Companies Regulations and FSRA rules, so that no unintended breaches or governance conflicts arise.

An acquirer might create an ADGM holding company to help with cross-border investment, consolidate multiple subsidiaries and benefit from ADGM's common law environment. This structure can provide clearer governance frameworks, particularly when dealing with international investors accustomed to common law jurisdictions.

Lapses after completion can trigger sanctions or shareholder disputes

Post-transaction, the combined entity must maintain compliance with the ADGM Companies Regulations and FSRA rules. This includes ongoing reporting, governance and AML/CTF obligations. Failure to do so can trigger regulatory sanctions or shareholder disputes.

Legal teams must build compliance programmes and reporting structures that reduce the risk of regulatory intervention. These include training, internal controls and continuous monitoring aligned with evolving FSRA guidance.

Foreign investment controls, tax treaties and foreign regulators

Given ADGM's status as an international financial centre, many M&A transactions there involve cross-border elements. These introduce additional layers of complexity, including foreign investment restrictions, double taxation treaties and extraterritorial regulatory requirements.

Although ADGM maintains an open investment environment, certain sectors may be subject to restrictions or require government approvals. Acquirers from foreign jurisdictions must handle these controls carefully and structure their transactions to comply. Energy or infrastructure-related transactions, for instance, may attract scrutiny under UAE federal laws, requiring coordination between ADGM authorities and mainland regulators to avoid regulatory conflicts.

Cross-border M&A within ADGM must consider applicable double taxation treaties and local tax laws. Coordination with tax advisers is essential to manage tax exposure and avoid outcomes such as double taxation or tax penalties.

Transactions involving regulated entities may also trigger notifications or approvals from foreign regulators, such as the Securities and Exchange Commission (SEC) in the US or the European Central Bank (ECB). Legal teams must design disclosure and compliance protocols that satisfy multiple jurisdictions and avoid conflicts and delays.